\u4f01\u696d\u306f\u30b9\u30d4\u30fc\u30c9\u3068\u52b9\u7387\u6027\u306e\u5411\u4e0a\u3092\u6c42\u3081\u3066Veeva Vault EDC\u306b\u79fb\u884c<\/p>\n
<\/p>\n
2023\u5e745\u670812\u65e5
\nVeeva Japan\u682a\u5f0f\u4f1a\u793e<\/p>\n
<\/p>\n
Veeva Systems<\/a><\/strong>\u3010NYSE:VEEV\u3011\uff08\u672c\u793e\uff1a\u30ab\u30ea\u30d5\u30a9\u30eb\u30cb\u30a2\u5dde\u30d7\u30ec\u30b6\u30f3\u30c8\u30f3\u3001\u65e5\u672c\u6cd5\u4eba \u672c\u793e\uff1a\u6771\u4eac\u90fd\u6e0b\u8c37\u533a\u3001\u65e5\u672c\u6cd5\u4eba\u4ee3\u8868\u53d6\u7de0\u5f79\uff1aSebastian Bather\u3001\u4ee5\u4e0bVeeva\uff09\u306f\u3001\u5927\u624b\u4f01\u696d\uff08\u88fd\u85ac\u4f01\u696d\u306e\u4e0a\u4f4d20\u793e\u306e\u3046\u30616\u793e\u3092\u542b\u3080\uff09\u306b\u3088\u308b\u81e8\u5e8a\u30c7\u30fc\u30bf\u7ba1\u7406\u306e\u8fd1\u4ee3\u5316\u3078\u306e\u79fb\u884c\u306b\u4f34\u3044\u3001Veeva Vault EDC<\/a><\/strong>\u306e\u63a1\u7528\u5897\u52a0\u306b\u3064\u304d\u767a\u8868\u3057\u307e\u3057\u305f\u3002Veeva Vault EDC\u306e\u9ad8\u5ea6\u306a\u30c7\u30fc\u30bf\u6a5f\u80fd\u3092\u6d3b\u7528\u3057\u3066\u30b9\u30bf\u30c7\u30a3\u69cb\u7bc9\u3068\u30c7\u30fc\u30bf\u51e6\u7406\u3092\u5408\u7406\u5316\u3059\u308b\u3053\u3068\u306b\u3088\u308a\u3001\u4f01\u696d\u306f\u6642\u9593\u3001\u52b4\u529b\u3001\u30b3\u30b9\u30c8\u3092\u5927\u5e45\u306b\u524a\u6e1b\u3057\u3001\u6cbb\u9a13\u5b9f\u65bd\u65bd\u8a2d\u306e\u30a8\u30af\u30b9\u30da\u30ea\u30a8\u30f3\u30b9\u3092\u5411\u4e0a\u3059\u308b\u3053\u3068\u304c\u3067\u304d\u307e\u3059\u3002\uff08\u672c\u30ea\u30ea\u30fc\u30b9\u306f\u3001Veeva\u7c73\u56fd\u672c\u793e\u304c\u767a\u8868\u3057\u305f\u5831\u9053\u8cc7\u6599\u306e\u6284\u8a33\u3067\u3059\u3002\u539f\u6587\u306f\u3053\u3061\u3089<\/a>\u304b\u3089\u304a\u8aad\u307f\u3044\u305f\u3060\u3051\u307e\u3059\u3002\uff09<\/p>\n <\/p>\n \u8a66\u9a13\u304c\u307e\u3059\u307e\u3059\u8907\u96d1\u306b\u306a\u308a\u3001\u30d0\u30a4\u30aa\u533b\u85ac\u54c1\u4f01\u696d\u306f\u3001\u81e8\u5e8a\u30c1\u30fc\u30e0\u304c\u3042\u3089\u3086\u308b\u7a2e\u985e\u306e\u8a66\u9a13\u3092\u8fc5\u901f\u306b\u8a2d\u8a08\u3001\u958b\u59cb\u3001\u5b9f\u884c\u3001\u4fee\u6b63\u3067\u304d\u308b\u30a2\u30b8\u30e3\u30a4\u30eb\u30b7\u30b9\u30c6\u30e0\u3092\u5fc5\u8981\u3068\u3057\u3066\u3044\u307e\u3059\u3002Veeva Vault EDC\u306f\u3001\u624b\u52d5\u30d7\u30ed\u30bb\u30b9\u3092\u81ea\u52d5\u5316\u3057\u3001\u30b9\u30bf\u30c7\u30a3\u69cb\u7bc9\u3092\u3088\u308a\u8fc5\u901f\u306b\u3067\u304d\u308b\u30c0\u30a4\u30ca\u30df\u30c3\u30af\u306a\u8a2d\u8a08\u30c4\u30fc\u30eb\u3092\u63d0\u4f9b\u3057\u307e\u3059\u3002\u8a66\u9a13\u904b\u7528\u4e2d\u3001Veeva Vault EDC\u30e6\u30fc\u30b6\u30fc\u306f\u30b3\u30b9\u30c8\u306e\u304b\u304b\u308b\u30c7\u30fc\u30bf\u79fb\u884c\u3092\u884c\u3046\u3053\u3068\u306a\u304f\u4fee\u6b63\u3059\u308b\u3053\u3068\u304c\u3067\u304d\u307e\u3059\u3002<\/p>\n Veeva\u306eVault CDMS\u62c5\u5f53\u30f4\u30a1\u30a4\u30b9\u30d7\u30ec\u30b8\u30c7\u30f3\u30c8\u3067\u3042\u308bRichard Young\u306f\u3001\u6b21\u306e\u3088\u3046\u306b\u30b3\u30e1\u30f3\u30c8\u3057\u3066\u3044\u307e\u3059\u3002\u300c\u696d\u754c\u3067\u306f\u60a3\u8005\u3055\u3093\u4e2d\u5fc3\u306e\u8a66\u9a13\u3078\u306e\u79fb\u884c\u304c\u5927\u304d\u304f\u9032\u6b69\u3057\u3064\u3064\u3042\u308a\u307e\u3059\u3002\u79c1\u305f\u3061\u306f\u3001\u8907\u96d1\u306a\u79d1\u5b66\u7684\u53d6\u308a\u7d44\u307f\u3068\u81e8\u5e8a\u30c7\u30fc\u30bf\u7ba1\u7406\u3092\u5411\u4e0a\u3059\u308b\u30aa\u30da\u30ec\u30fc\u30b7\u30e7\u30ca\u30eb\u30fb\u30a8\u30af\u30bb\u30ec\u30f3\u30b9\u3068\u306e\u30d0\u30e9\u30f3\u30b9\u3092\u3068\u308b\u305f\u3081\u30c7\u30fc\u30bf\u30de\u30cd\u30fc\u30b8\u30e3\u30fc\u3089\u304c\u5fc5\u8981\u3068\u3059\u308b\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u3092\u63d0\u4f9b\u3059\u308b\u3053\u3068\u306b\u5c3d\u529b\u3057\u3066\u3044\u307e\u3059\u3002\u5f53\u793e\u306e\u304a\u5ba2\u69d8\u3001\u7279\u306b\u65e9\u671f\u306b\u63a1\u7528\u3057\u3066\u9802\u3044\u305f\u304a\u5ba2\u69d8\u306b\u306f\u3001\u79c1\u305f\u3061\u304c\u88fd\u54c1\u63d0\u4f9b\u3092\u6210\u719f\u3055\u305b\u3066\u3044\u304f\u4e2d\u3067\u3001\u904e\u53bb\u6570\u5e74\u9593\u306b\u6e21\u308a\u5bc6\u63a5\u306b\u63d0\u643a\u3057\u3066\u9802\u304d\u3001\u611f\u8b1d\u7533\u3057\u4e0a\u3052\u307e\u3059\u3002\u300d<\/p>\n Veeva Vault EDC\u306fVeeva Vault Clinical Suite<\/a><\/strong>\u306e\u4e00\u90e8\u3067\u3042\u308a\u3001Veeva Vault CTMS<\/a><\/strong>\u3068\u7d71\u5408\u3059\u308b\u3053\u3068\u3067\u3001CRA\u3068\u4ed6\u306e\u81e8\u5e8a\u5c02\u9580\u5bb6\u306f\u3001\u52b9\u7387\u7684\u306a\u904b\u7528\u306e\u305f\u3081\u306e\u30b7\u30fc\u30e0\u30ec\u30b9\u306a\u30c7\u30fc\u30bf\u30d5\u30ed\u30fc\u3068\u512a\u308c\u305f\u30e6\u30fc\u30b6\u30fc\u30a4\u30f3\u30bf\u30fc\u30d5\u30a7\u30a4\u30b9\u304a\u3088\u3073\u30ef\u30fc\u30af\u30d5\u30ed\u30fc\u304c\u53ef\u80fd\u306b\u306a\u308a\u307e\u3059\u3002<\/p>\n GSK\u793e\u306e\u30c7\u30fc\u30bf\u6226\u7565\u304a\u3088\u3073\u7ba1\u7406\u62c5\u5f53\u30f4\u30a1\u30a4\u30b9\u30d7\u30ec\u30b8\u30c7\u30f3\u30c8\u517c\u30b0\u30ed\u30fc\u30d0\u30eb\u30d8\u30c3\u30c9\u3067\u3042\u308bMayank Anand\u6c0f\u306f\u3001\u6b21\u306e\u3088\u3046\u306b\u30b3\u30e1\u30f3\u30c8\u3057\u3066\u3044\u307e\u3059\u3002\u300cVeeva Vault EDC\u306e\u9769\u65b0\u7684\u306a\u6a5f\u80fd\u3092\u4f7f\u7528\u3059\u308b\u3053\u3068\u3067\u3001\u30b9\u30bf\u30c7\u30a3\u69cb\u7bc9\u306e\u30bf\u30a4\u30e0\u30e9\u30a4\u30f3\u30922021\u5e74\u4ee5\u524d\u3068\u6bd4\u8f03\u3057\u306630\uff5e35\uff05\u6539\u5584\u3059\u308b\u3053\u3068\u304c\u3067\u304d\u307e\u3057\u305f\u3002Veeva \u306f\u672a\u6765\u306b\u5411\u3051\u305f\u5f53\u793e\u306e\u30c7\u30fc\u30bf\u6226\u7565\u306e\u91cd\u8981\u306a\u5f79\u5272\u3092\u62c5\u3063\u3066\u3044\u307e\u3059\u3002\u300d<\/p>\n Cara Therapeutics\u793e\u306e\u30c7\u30fc\u30bf\u7ba1\u7406\u30c7\u30a3\u30ec\u30af\u30bf\u30fc\u3067\u3042\u308bEvelyn Dorsey\u6c0f\u306f\u3001\u6b21\u306e\u3088\u3046\u306b\u30b3\u30e1\u30f3\u30c8\u3057\u3066\u3044\u307e\u3059\u3002\u300cVeeva Vault EDC\u306f\u3001\u69d8\u3005\u306aCRO\u3068\u9023\u643a\u3057\u306a\u304c\u3089\u3082\u30c7\u30fc\u30bf\u306b\u4e00\u8cab\u6027\u304c\u751f\u307e\u308c\u3001\u30b9\u30bf\u30c7\u30a3\u69cb\u7bc9\u3068\u4fee\u6b63\u306e\u8fc5\u901f\u5316\u306b\u3064\u306a\u304c\u308a\u307e\u3057\u305f\u3002\u5f53\u793e\u306f\u73fe\u5728\u3001\u30d5\u30ec\u30ad\u30b7\u30d6\u30eb\u306a\u30ec\u30dd\u30fc\u30c6\u30a3\u30f3\u30b0\u3092\u6d3b\u7528\u3057\u3066\u30ab\u30b9\u30bf\u30e0\u6307\u6a19\u3092\u5171\u6709\u3057\u3001CRO\u30c1\u30fc\u30e0\u30e1\u30f3\u30d0\u30fc\u306b\u5bb9\u6613\u306b\u30a2\u30af\u30bb\u30b9\u3067\u304d\u307e\u3059\u3002\u305d\u306e\u7d50\u679c\u3001\u30b3\u30e9\u30dc\u30ec\u30fc\u30b7\u30e7\u30f3\u3092\u5bb9\u6613\u306b\u3057\u3001\u5168\u4f53\u52b9\u7387\u3092\u5411\u4e0a\u3059\u308b\u3053\u3068\u304c\u3067\u304d\u308b\u3088\u3046\u306b\u306a\u308a\u307e\u3057\u305f\u3002\u300d<\/p>\n Labcorp Drug Development\u793e\u306eCOO\u3067\u3042\u308bMark Morais\u6c0f\u306f\u3001\u6b21\u306e\u3088\u3046\u306b\u30b3\u30e1\u30f3\u30c8\u3057\u3066\u3044\u307e\u3059\u3002\u300c\u79c1\u305f\u3061\u306f\u3001\u30d1\u30fc\u30c8\u30ca\u30fc\u30b7\u30c3\u30d7\u3092\u767a\u5c55\u3055\u305b\u3001Veeva Vault EDC\u3092\u6a19\u6e96\u904b\u7528\u30e2\u30c7\u30eb\u306e\u4e00\u90e8\u3068\u3059\u308b\u3053\u3068\u306b\u8208\u596e\u3057\u3066\u3044\u307e\u3059\u3002Veeva Vault EDC\u306b\u3088\u308a\u3001\u30c7\u30fc\u30bf\u904b\u7528\u306e\u8fd1\u4ee3\u5316\u3001\u30b9\u30bf\u30c7\u30a3\u69cb\u7bc9\u3068\u4fee\u6b63\u306e\u8fc5\u901f\u5316\u3001\u6700\u7d42\u7684\u306b\u306f\u8a66\u9a13\u30c7\u30fc\u30bf\u306e\u3088\u308a\u52b9\u679c\u7684\u306a\u63d0\u4f9b\u3092\u5b9f\u73fe\u3059\u308b\u3053\u3068\u304c\u3067\u304d\u307e\u3057\u305f\u3002\u300d<\/p>\n Platform Life Sciences\u793e\u306e\u30c7\u30fc\u30bf\u7ba1\u7406\u62c5\u5f53\u30f4\u30a1\u30a4\u30b9\u30d7\u30ec\u30b8\u30c7\u30f3\u30c8\u3067\u3042\u308bMichael Lambert\u6c0f\u306f\u3001\u6b21\u306e\u3088\u3046\u306b\u30b3\u30e1\u30f3\u30c8\u3057\u3066\u3044\u307e\u3059\u3002\u300c\u79c1\u305f\u3061\u306f\u3001\u5927\u898f\u6a21\u306a\u60a3\u8005\u3055\u3093\u306e\u96c6\u56e3\u3092\u5bfe\u8c61\u3068\u3057\u305f\u7b2cI\u76f8\u3001\u7b2cII\u76f8\u3001\u304a\u3088\u3073\u7b2cIII\u76f8\u8a66\u9a13\u306e\u30b0\u30ed\u30fc\u30d0\u30eb\u9069\u5fdc\u578b\u306e\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306e\u904b\u7528\u306b\u91cd\u70b9\u3092\u7f6e\u3044\u3066\u304a\u308a\u3001\u30b9\u30bf\u30c7\u30a3\u306e\u52d5\u7684\u306a\u6027\u8cea\u306b\u5bfe\u5fdc\u3067\u304d\u308b\u96fb\u5b50\u30c7\u30fc\u30bf\u53ce\u96c6\u30b7\u30b9\u30c6\u30e0\u3092\u5fc5\u8981\u3068\u3057\u3066\u3044\u307e\u3057\u305f\u3002Veeva Vault EDC\u3092\u4f7f\u7528\u3059\u308b\u3053\u3068\u3067\u3001\u30c7\u30fc\u30bf\u30d1\u30a4\u30d7\u30e9\u30a4\u30f3\u3042\u308b\u3044\u306f\u30d7\u30ed\u30c8\u30b3\u30eb\u306b\u5909\u66f4\u3092\u7d44\u307f\u8fbc\u307f\u3001\u3088\u308a\u8fc5\u901f\u306b\u77e5\u898b\u3092\u5f97\u308b\u3053\u3068\u304c\u3067\u304d\u307e\u3059\u3002\u3053\u308c\u306b\u3088\u308a\u3001CRF\u307e\u305f\u306fICF\u306e\u4fee\u6b63\u306b\u8fc5\u901f\u306b\u5bfe\u5fdc\u3067\u304d\u3001\u8a66\u9a13\u3092\u7d9a\u3051\u308b\u3053\u3068\u304c\u3067\u304d\u307e\u3059\u3002\u300d<\/p>\n <\/p>\n \u3010Veeva Systems \u793e\u306b\u3064\u3044\u3066\u3011<\/strong> \u3010Veeva Forward-looking Statements\u3011<\/strong> \u5927\u624b\u4f01\u696d\uff08\u88fd\u85ac\u4f01\u696d\u306e\u4e0a\u4f4d20\u793e\u306e\u3046\u30616\u793e\u3092\u542b\u3080\uff09\u306b\u3088\u308b\u81e8\u5e8a\u30c7\u30fc\u30bf\u7ba1\u7406\u306e\u8fd1\u4ee3\u5316\u3078\u306e\u79fb\u884c\u306b\u4f34\u3044\u3001Veeva Vault EDC\u306e\u63a1\u7528\u5897\u52a0\u306b\u3064\u304d\u767a\u8868\u3002<\/p>\n","protected":false},"author":129,"featured_media":46014,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[322],"tags":[],"class_list":["post-48394","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-press-release"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/48394"}],"collection":[{"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/comments?post=48394"}],"version-history":[{"count":9,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/48394\/revisions"}],"predecessor-version":[{"id":48439,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/48394\/revisions\/48439"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/media\/46014"}],"wp:attachment":[{"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/media?parent=48394"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/categories?post=48394"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/tags?post=48394"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}Veeva Vault EDC\u306b\u5bfe\u3059\u308b\u696d\u754c\u306e\u53cd\u5fdc<\/h2>\n
\nVeeva Systems\u793e\u306f\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u4f01\u696d\u5411\u3051\u306b\u30af\u30e9\u30a6\u30c9\u30d9\u30fc\u30b9\u306e\u30bd\u30d5\u30c8\u30a6\u30a7\u30a2\u3092\u63d0\u4f9b\u3059\u308b\u30b0\u30ed\u30fc\u30d0\u30eb\u30ea\u30fc\u30c7\u30a3\u30f3\u30b0\u30ab\u30f3\u30d1\u30cb\u30fc\u3067\u3059\u3002\u4e16\u754c\u6700\u5927\u898f\u6a21\u306e\u88fd\u85ac\u4f01\u696d\u304b\u3089\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u5206\u91ce\u306e\u65b0\u8208\u4f01\u696d\u307e\u3067\u30011,100\u793e\u3092\u8d85\u3048\u308b\u9867\u5ba2\u306b\u6280\u8853\u9769\u65b0\u3078\u306e\u53d6\u308a\u7d44\u307f\u3084\u5353\u8d8a\u3057\u305f\u88fd\u54c1\u529b\u306b\u3088\u3063\u3066\u3001\u304a\u5ba2\u69d8\u306e\u6210\u529f\u306b\u30b3\u30df\u30c3\u30c8\u3059\u308b\u69d8\u3005\u306a\u30b5\u30fc\u30d3\u30b9\u3092\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002\u30d1\u30d6\u30ea\u30c3\u30af\u30fb\u30d9\u30cd\u30d5\u30a3\u30c3\u30c8\u30fb\u30b3\u30fc\u30dd\u30ec\u30fc\u30b7\u30e7\u30f3\u4f01\u696d\u3068\u3057\u3066Veeva\u306f\u3001\u304a\u5ba2\u69d8\u3084\u5f93\u696d\u54e1\u3001\u63d0\u643a\u4f01\u696d\u3001\u682a\u4e3b\u3001\u30b5\u30fc\u30d3\u30b9\u63d0\u4f9b\u696d\u754c\u3092\u542b\u3080\u3059\u3079\u3066\u306e\u30b9\u30c6\u30fc\u30af\u30db\u30eb\u30c0\u30fc\u306e\u5229\u76ca\u30d0\u30e9\u30f3\u30b9\u3092\u4fdd\u3064\u3053\u3068\u306b\u30b3\u30df\u30c3\u30c8\u3057\u307e\u3059\u3002\u8a73\u3057\u304f\u306f\u3001https:\/\/veeva.com\/jp\/<\/a>\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002<\/p>\n
\nThis release contains forward-looking statements regarding Veeva\u2019s products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-Q for the period ended October 31, 2022, which you can find\u00a0here<\/a> (a summary of risks which may impact our business can be found on pages 39 and 40), and in our subsequent SEC filings, which you can access at\u00a0sec.gov<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"